Please login to the form below

Not currently logged in
Email:
Password:

Disruptive technologies set to stabilise soaring drug prices

AI and blockchain could accelerate the drug development process, says report

robot

The pharmaceutical industry has been no stranger to the rising costs of drug development as of late, but disruptive technologies could soon change this paradigm, according to a report by GlobalData.

Artificial intelligence (AI), big data and blockchain are set to impact the industry, not only by helping to add value in terms of personalised treatments, but to also counteract the unsustainability of skyrocketing drug prices, according to the data and analytics company.

The report states that there are currently over 100 companies applying AI to healthcare, with big names such as Google, Microsoft, Amazon and IBM Watson paving the way.

With the new technology, researchers are hoping to “generate more accurate hypotheses faster, making the drug discovery process less expensive and more effective”, said Valentina Gburcik, GlobalData’s cardiovascular and metabolic disease director.

She added: “In addition, the database of electronic medical records and public health data can be analysed to identify hidden patterns that can lead to a quick identification of potential molecular targets for a disease.”

And it’s not just the pharmaceutical industry that is set to see the change either. Quite recently it was reported that health insurers are also testing blockchain’s capabilities in generating more accurate and reliable demographic data, such as health records.

Gburcik concluded: “Blockchain could be a platform for sharing electronic health records between various health organisations in a secure way, which would further facilitate research and speed up the drug development process.

“Furthermore, there is a great potential for using this technology in pharmaceutical supply chain, medical billing and anonymised patient record transmission.”

Article by
Gemma Jones

1st May 2018

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics